Research library / Longevity compounds
DD Mostly mechanistic or early data. Shown openly. How we grade →Trial protocol · 187 adults over 65 with coronary disease, 48 weeks
POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial of spermidine treatment versus placebo
C Thorup, C Jeppesen, T Jensen, A Tinggaard, C Hvas, C Rud et al. Trials. 2025.
- In plain language
- Protocol for a 24 mg a day spermidine trial with heart, fitness, muscle and inflammation endpoints.
- Limits
- Protocol only; completed June 2026, no published results found as of 17 Oct 2026.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Spermidine
- Source
- doi.org/10.1186/s13063-025-09176-z · PubMed 41168834 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.